NCT01513915

Brief Summary

The fact that Cognitive Behavioral Therapy (CBT) is a well known efficacious intervention for children with anxiety disorders (AD) is undeniable. However, most children with AD have limited access to CBT. There is some controversial evidence on group CBT in AD involving families in treatment of their children and a published article on efficacy of a parent only group CBT for these children. Considering these data, the investigators hypothesized that teaching anxiety-fighting skills to parents of children with AD would diminish anxiety symptoms of both parents and children and improve family relational functioning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2008

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2009

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

January 16, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 20, 2012

Completed
Last Updated

April 26, 2016

Status Verified

April 1, 2016

Enrollment Period

10 months

First QC Date

January 16, 2012

Last Update Submit

April 23, 2016

Conditions

Keywords

parentsgroup cognitive behavioral interventionanxiety disorderchildrenFRIENDS program

Outcome Measures

Primary Outcomes (1)

  • Revised Children's Manifest Anxiety (RCMA)

    This self report questionnaire consists of 28 items assessing a child's chronic or trait anxiety and 9 items assessing social desirability or potential lying. The RCMA has achieved a high internal consistency and moderate test-retest reliability.

    up to 30 minutes

Secondary Outcomes (6)

  • Children's Depression Inventory (CDI)

    20 minutes

  • Depression-Anxiety-Stress Scale (DASS)

    20 minutes

  • Children Global Assessment Scale (CGAS)

    15 minutes

  • Assessment of Consumer Satisfaction

    25 minutes

  • Strengths and Difficulties Questionnaire (SDQ) Home Version

    [Time Frame: 30 minutes]

  • +1 more secondary outcomes

Study Arms (2)

A parent only group CBT

ACTIVE COMPARATOR

There was a Group cognitive behavioral intervention -based on parent training component of "FRIENDS" program- for parents of children with anxiety disorders who were allocated to intervention group.

Other: Group cognitive behavioral intervention

Waiting list group

NO INTERVENTION

Parents of children with anxiety disorders who met the inclusion criteria and gave written informed consent and were allocated to wait list group.

Interventions

A Group cognitive behavioral intervention \_based on parent training component of FRIENDS program\_ was performed.The program protocol was translated to Persian, using the back translation method.The intervention was delivered in 6 two-hour weekly sessions. Two intervention groups ran, each group included 10 parents.The therapy was provided by an attending board certified child and adolescent psychiatrist and co lead by a fellow of child and adolescent psychiatry who distributed psychometric procedures and completed treatment adherence ratings.

A parent only group CBT

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • having DSM-IV criteria for a primary diagnosis of generalized anxiety disorder (GAD), separation anxiety disorder (SAD), social phobia, or specific phobia.
  • age 6 to 12 years,
  • receiving one of selective serotonin reuptake inhibitor (SSRI) medicine at the stable dose for at least 8 weeks before baseline assessments and during the study,
  • at least one parent willing to participate and give written consent.

You may not qualify if:

  • diagnosed as bipolar disorder, autism spectrum disorders or mental disability by data obtained in personal history and clinical assessments,
  • there was a change in drug regime during the study period,
  • if parents missed more than 2 of 6 sessions of treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rouzbeh Hospital

Tehran, Tehran Province, 13333, Iran

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Zahra Shahrivar, MD

    Tehran University of Medical Sciences

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 16, 2012

First Posted

January 20, 2012

Study Start

July 1, 2008

Primary Completion

May 1, 2009

Study Completion

July 1, 2009

Last Updated

April 26, 2016

Record last verified: 2016-04

Locations